Chembio Diagnostics closes $6M offering; Device research vulnerable to sequestration effects;

@FierceMedDev: Dako gains FDA blessing for breast cancer antibody Dx agent. More | Follow @FierceMedDev

@MarkHFierce: Japan is dropping reimbursement rates for interventional cardiology devices. Not a good development for business. Story | Follow @MarkHFierce

 @DamianFierce: Bausch + Lomb has a date with the FDA for its intraocular lens implant. Article | Follow @DamianFierce

> Academic-related medical device research is increasingly threatened by the federal funding cuts known as sequestration. Story

> Sweden's Aerocrine won Japanese regulatory approval to use Niox Mino, its fractional exhaled nitric oxide-measuring device to assess asthmatic patients and others with inflamed airways. Release

> Lensar nailed down a 510(k) clearance for its cataract surgery laser device. Story

> Chembio Diagnostics ($CEMI) closed a $6 million public offering. Plans call for using the money, in part, to fuel an expansion of the company's rapid diagnostic tests offerings. Item

> AliveCor, maker of a new mobile heart monitor, named Daniel Sullivan as its new president and CEO. He replaces Judy Wade, who left the company in December. Story

> Scientists at Case Western Reserve University are using a squid's beak as a model for safer and more comfortable medical devices, in part because of its combination of extremely hard and soft, durable materials. Release

> A cardiologist at Pennsylvania Hospital in Philadelphia has resigned in the wake of an investigation that found patients received cardiac stents even when they didn't need them. Story

Biotech News

@FierceBiotech: #1 biotech billionaire on our list? @BillGates | Full report | Follow @FierceBiotech

@JohnCFierce: The biotech gods taketh away, and they giveth. Regeneron expanding, adding 400 jobs. More | Follow @JohnCFierce.

@RyanMFierce: Pfizer made another early-stage deal with a Cambridge, MA biotech. This one with Gates-backed Tetragenics. Release | Follow @RyanMFierce

> Merrimack's lead lung cancer drug flunks first of three PhII tests. Article

> Can Merck use animal data to make its case against Lunesta, Ambien? More

> Bristol-Myers shuttering Amylin's San Diego HQ, laying off hundreds. Report

> Celgene-backed Agios and Foundation partner in breakthrough cancer strategy. News

Pharma News

@FiercePharma: Analysts expect nanotech drug delivery boom despite safety concerns. Article | Follow @FiercePharma

@EricPFierce: Pfizer recalls 52,000 bottles of its thyroid pill Levoxyl because of a bad odor. More | Follow @EricPFierce

> Big Pharma shows its claws with new compensation policies. Article

> Novartis aims new Gilenya campaign at young MS patients. Report

> Pfizer fails to block $142M Neurontin award, faces 2 more suits. Story

Pharma Manufacturing News

> Industry ready to resurrect track and trace negotiations. Report

> Pfizer has another recall tied to smelly drugs. More

> Canada compounding pharmacy linked to weak chemo drugs. Story

> Frazier grabs AndersonBrecon as it bulks up in packaging. Article

Vaccines News

> JAMA paper delves into Merck staph vaccine flunk. Item

> Text message campaign fails to boost vaccination rate. Article

> U.S. keeping rubella at bay as virus takes toll globally. More

> Autism argument again undermined by vaccine data. Story

> Merck vax condemning pox to past. Report

Suggested Articles

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.

Insulet announced new agreements with Abbott and Dexcom to connect their continuous glucose monitors with its upcoming tubeless, digital insulin pump,